Articles tagged with Neuromuscular Diseases
Scientists discover that activating TAK1 in skeletal muscle promotes muscle growth and prevents atrophy, with implications for treating conditions like cancer, COPD, and genetic diseases. The research also highlights the importance of maintaining healthy neuromuscular junctions.
Researchers uncover the pleiotropic functions of hnRNPK in regulating skeletal muscle cell differentiation, including inhibition of myoblast differentiation and suppression of genes involved in endoplasmic reticulum stress. The study suggests that targeting hnRNPK could be a potential therapeutic strategy for treating human disorders.
A study by Harvard T.H. Chan School of Public Health researchers found a strong association between Epstein-Barr virus infection and multiple sclerosis. The risk of MS increased 32-fold after EBV infection, while serum levels of neurofilament light chain, a biomarker of nerve degeneration, only increased after EBV infection.
A study by GIST scientists found that physical interaction between children with cerebral palsy and horses improves motor skills and balance. The research team recorded horse and child movements, tracking acceleration and angular velocity to quantify interactions, which were linked to improved outcomes.
Researchers highlight the importance of sharing well-conducted studies with negative or irreproducible results, even if they disprove a hypothesis. The Journal of Neuromuscular Diseases special issue on 'The Null Hypothesis' presents eight articles that contribute valuable information to the scientific record.
Researchers developed a wearable, biocompatible, and low-cost biosensor that measures electromyography signals in muscles. The sensor uses a gold-silver nanocomposite printed onto fabric, providing a comfortable and effective way to track muscle activity.
A study published in the Journal of Neuromuscular Diseases found Nusinersen treatment improved motor and respiratory functions in adults with longstanding SMA3. Functional testing showed significant improvements on the 6-Minute-Walk-Test, with patients experiencing a mean improvement of 8.25 meters.
A new position paper published in the Journal of Neuromuscular Diseases emphasizes the importance of patient-centered approach in neuromuscular disease research. The paper advocates for shared decision-making and patient involvement in research activities, including clinical trials, biobanks, and regulatory processes.
Researchers at Karolinska Institutet have discovered a new way in which nerve cells control movement by dynamically adjusting neurotransmitter production. This finding opens up new avenues for treating diseases such as myasthenia gravis and spinal muscular atrophy.
A new study published in the New England Journal of Medicine found that Spinraza significantly improves outcomes for children with spinal muscular atrophy type 2, who have not yet begun to walk. The drug also shows promise for reversing muscle weakness and improving mobility.
Scientists uncover fragile alliance between SMN protein and Gemins that leads to SMA. Disrupting this balance causes catastrophic consequences, including death in flies and muscle weakness.
Researchers have discovered a plant-based compound that targets the root cause of spinal muscular atrophy (SMA), a genetic disorder causing muscle wastage and weakness in infants. Quercetin has shown promise in tests on zebra fish, mice, and fruit flies, offering a potential treatment option for early stages of the disease.
Researchers have discovered a plant pigment called quercetin that targets the mutated gene causing spinal muscular atrophy (SMA), a leading genetic cause of death in children. Quercetin has been shown to improve nerve and muscle cell health in tests on zebra fish, mice, and fruit flies.
Research identifies pivotal role of proteins in cellular and disease processes, shedding light on neuromuscular disorder and cancer connections. The study found that impaired Mpc1 and Mpc2 lead to deadly health problems, including the neuromuscular disorder.
A study found that invasive treatment strategies, including heart testing and pacemaker implantation, can increase survival rates for patients with myotonic dystrophy type 1. The treatment approach resulted in a lower incidence of sudden death and improved overall survival.
Researchers quantified needle grasp by measuring pullout force, finding that two types of needle rotation had greater effects than no manipulation. These findings suggest a potential role for manual needle manipulation in acupuncture therapy.